Beijing Tong Ren Tang Chinese Medicine Company Limited

Equities

3613

HK0000145638

Pharmaceuticals

Market Closed - Hong Kong S.E. 03:08:17 2024-12-13 am EST 5-day change 1st Jan Change
8.330 HKD -2.34% Intraday chart for Beijing Tong Ren Tang Chinese Medicine Company Limited +0.60% -31.38%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Beijing Tong Ren Tang Chinese Medicine Company Limited Reports Earnings Results for the Half Year Ended June 30, 2024 Aug. 30 CI
Tong Ren Tang Chinese Medicine Appoints CEO May. 13 MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Appoints Wang Chi as an Executive Director and a Member of the Competition Executive Committee May. 10 CI
Beijing Tong Ren Tang Chinese Medicine Company Limited Announces CEO Changes May. 10 CI
Beijing Tong Ren Tang Gets Nod to Sell Fever Drug in Hong Kong Apr. 30 MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Announcement on Receiving the Certificate of Registration of Proprietary Chinese Medicine Apr. 30 CI
Beijing Tong Ren Tang Chinese Medicine CEO Steps Down; Acting CEO Appointed Mar. 28 MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Announces CEO Changes Mar. 28 CI
Beijing Tong Ren Tang Chinese Medicine Company Limited Announces Resignation of Yu Jin as an Executive Director and Member of the Competition Executive Committee Mar. 28 CI
Beijing Tong Ren Tang Chinese Medicine Signs E-Commerce Framework Agreement Mar. 15 MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 Mar. 14 CI
Beijing Tong Ren Tang Flags Up to 22% Profit Drop in 2023 Jan. 29 MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Provides Earnings Guidance for the Year Ended 31 December 2023 Jan. 29 CI
Beijing Tong Ren Tang Appoints Chairman Dec. 13 MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Appoints Gu Hai Ou as Executive Director, Chairman of Board and Authorised Representative Dec. 13 CI
Beijing Tong Ren Tang to Vote Dec. 27 on Renewal of Distributorship Contracts Dec. 05 MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Proposes New Exclusive Distributorship Framework Agreements Nov. 29 CI
Chinese listed firms used endangered animal parts as ingredients -report 23-10-23 RE
Three listed Chinese firms used endangered animal parts as ingredients- report 23-10-22 RE
Beijing Tong Ren Tang Chinese Medicine Company Limited Appoints Mr. Yu Jin as Executive Director and A Member of Competition Executive Committee 23-10-20 CI
Sinopharm CFO Retires; Successor Named 23-10-16 MT
Beijing Tong Ren Tang Chinese Medicine COO Resigns 23-09-12 MT
Beijing Tong Ren Tang Chinese Medicine Company Limited Announces Resignation of Lin Man as Executive Director, Chief Operating Officer, Member of Competition Executive Committee 23-09-12 CI
Beijing Tong Ren Tang Chinese Medicine Company Limited Announces Retirement of Ding Yong Ling as Executive Director and Chairman of the Board 23-08-31 CI
Beijing Tong Ren Tang's Profit Jumps 23.9% in H1 23-08-11 MT
Chart Beijing Tong Ren Tang Chinese Medicine Company Limited
3613: Dynamic Chart
Logo Beijing Tong Ren Tang Chinese Medicine Company Limited
Beijing Tong Ren Tang Chinese Medicine Company Limited is a company mainly engaged in the manufacturing and sale of Chinese medicine. Along with subsidiaries, it operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. It is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.
Employees
779
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
surperformance-ratings-light-chart BEIJING-TONG-REN-TANG-CHIMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8.530HKD
Average target price
12.05HKD
Spread / Average Target
+41.27%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 3613 Stock
  4. News Beijing Tong Ren Tang Chinese Medicine Company Limited
  5. Beijing Tong Ren Tang Chinese Medicine CEO Steps Down; Acting CEO Appointed